ResearcherUniversity of WrocławNo recent work listed
Przemysław Duda
Matched on ORCID iD 0000-0001-5207-4157; OpenAlex author ID A5027666108. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2022: 3 papers
Papers 3
- Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1… Co-author DOI 10.18632/aging.204038↗
- APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells. Last author DOI 10.3390/biom12020276↗
- Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53. First author DOI 10.3390/cells11050794↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stephen Lee Abrams · 3 shared papers, 2022 · strength 0.43
- Paper APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Pro… DOI 10.3390/biom12020276↗
- Paper Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic … DOI 10.18632/aging.204038↗
- Paper Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence an… DOI 10.3390/cells11050794↗
- James Andrew McCubrey · 3 shared papers, 2022 · strength 0.43
- Paper APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Pro… DOI 10.3390/biom12020276↗
- Paper Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic … DOI 10.18632/aging.204038↗
- Paper Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence an… DOI 10.3390/cells11050794↗
- Agnieszka Gizak · 3 shared papers, 2022 · strength 0.43
- Paper APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Pro… DOI 10.3390/biom12020276↗
- Paper Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic … DOI 10.18632/aging.204038↗
- Paper Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence an… DOI 10.3390/cells11050794↗
- Shaw M. Akula · 2 shared papers, 2022 · strength 0.27
- Paper Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic … DOI 10.18632/aging.204038↗
- Paper Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence an… DOI 10.3390/cells11050794↗
- Melchiorre Cervello · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.